Lam Research Corp
(LRCX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,337,056 | 5,305,648 | 4,484,716 | 4,256,499 | 3,522,001 |
| Marketable Securities | N/A | 63,849 | 103,130 | 120,551 | 135,731 |
| Receivables | 2,823,376 | 3,262,140 | 4,070,088 | 4,569,735 | 4,313,818 |
| Inventories | 4,816,190 | 4,881,935 | 4,819,966 | 4,360,325 | 3,966,294 |
| Other current assets | -2 | 3 | 2 | -4 | 5 |
| TOTAL | $13,228,410 | $13,730,030 | $13,708,790 | $13,612,660 | $12,285,240 |
| Non-Current Assets | |||||
| PPE Net | 1,856,672 | 1,855,117 | 1,863,155 | 1,718,791 | 1,647,587 |
| Intangibles | 1,790,943 | 1,801,819 | 1,805,218 | 1,624,932 | 1,616,963 |
| Other Non-Current Assets | 1,905,616 | 1,856,398 | 1,829,220 | 1,764,895 | 1,645,847 |
| TOTAL | $5,553,231 | $5,513,334 | $5,497,593 | $5,108,618 | $4,910,397 |
| Total Assets | $18,781,640 | $19,243,360 | $19,206,380 | $18,721,280 | $17,195,630 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,358 | 8,457 | 7,226 | 7,110 | 7,381 |
| Accounts payable and accrued liabilities | 470,702 | 601,930 | 919,408 | 1,146,286 | 1,011,208 |
| Accrued Expenses | 2,010,637 | 1,990,147 | 2,068,370 | 1,948,776 | 1,974,272 |
| TOTAL | $4,184,918 | $4,441,329 | $4,546,922 | $5,053,382 | $4,564,759 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,003,183 | 4,996,920 | 4,996,057 | 4,996,363 | 4,998,449 |
| Deferred Revenues | 1,695,221 | 1,840,795 | 1,551,918 | 1,951,210 | 1,571,898 |
| Other Non-Current Liabilities | 1,383,370 | 1,397,724 | 1,358,767 | 1,258,970 | 1,354,058 |
| TOTAL | $6,386,553 | $6,394,644 | $6,354,824 | $6,255,333 | $6,352,507 |
| Total Liabilities | $10,571,470 | $10,835,970 | $10,901,750 | $11,308,710 | $10,917,270 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,325,117 | 1,343,405 | 1,349,362 | 1,363,793 | 1,369,878 |
| Common Shares | 133 | 135 | 135 | 136 | 137 |
| Retained earnings | 22,032,100 | 21,460,120 | 20,879,150 | 19,644,620 | 18,454,720 |
| Other shareholders' equity | -101,063 | -104,926 | -108,799 | -134,011 | -110,407 |
| TOTAL | $8,210,172 | $8,407,388 | $8,304,635 | $7,412,567 | $6,278,366 |
| Total Liabilities And Equity | $18,781,642 | $19,243,358 | $19,206,385 | $18,721,277 | $17,195,636 |